Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Ambulero Logo
Ambulero Growth Score
61
CB Rank
45131
Heat Score
67
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Founded
obfuscation
PrivateSeed Miami, Florida, United States1-10 www.ambulero.com/
Biotechnology
Genetics
Life Science
Therapeutics
Overview

Ambulero
Total Funding
obfuscation
Growth Score
61
Heat Score
67

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score61
25 pts
in past quarter
Heat Score 67
-10 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Ambulero

CB Rank
45131
Ambulero is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Founded
obfuscation
PrivateSeed Miami, Florida, United States1-10 www.ambulero.com/
Biotechnology
Genetics
Life Science
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Key People

Details

Legal Name Ambulero, Inc.
Operating Status Active
Company Type For Profit
Founders  Omaida Velazquez, Randy Berholtz, Robert Buchanan, Zhao-Jun Liu
About the Company
Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease.
Contact Email canderson@ambulero.com
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

AMB-301 Gene Therapy
A gene therapy using an AAV vector to deliver and over-express E-selectin in tissues affected by a rare vascular disease to promote healing.
AMB-201 Gene Therapy
A gene therapy using an AAV vector to deliver and over-express E-selectin in ischemic tissues, targeting critical limb ischemia patients.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed
obfuscation
Seed Round - Ambulero Logo
Seed Round - Ambulero
1
obfuscation
Orphinic ScientificSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4

Employee Profiles

News

News and Press

News•Dec 10, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 26, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 11, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 28, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

58
-71.98%
 in past month

IT Spend

$79.4KThis year, Ambulero is projected to spend $79.4K on IT, according to Aberdeen.

Active Website Tech Count

3Ambulero is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.

Total IP

1Ambulero has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Ambulero's headquarters? Ambulero is located in Miami, Florida, United States.Who invested in Ambulero? Ambulero is funded by Orphinic Scientific.When was the last funding round for Ambulero? Ambulero closed its last funding round on
obfuscation
from a Seed round.Who are Ambulero's competitors? Alternatives and possible competitors to Ambulero may include Humacyte, Theradaptive, and  Capricor Therapeutics.How much funding has Ambulero raised to date? Ambulero has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(9fd75b2 1)
|